These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17982393)

  • 1. Bisphosphonate therapy for fibrous dysplasia.
    DiMeglio LA
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD; Orcel P
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome.
    O'Sullivan M; Zacharin M
    J Pediatr Orthop; 2002; 22(2):255-60. PubMed ID: 11856942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrous dysplasia protuberans in a patient with McCune-Albright syndrome.
    Hamadani M; Awab A; Rashid A; Ali T; Brown B
    J Coll Physicians Surg Pak; 2006 May; 16(5):376-7. PubMed ID: 16756788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
    Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative indications for bisphosphonate therapy.
    Landesberg R; Eisig S; Fennoy I; Siris E
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):27-34. PubMed ID: 19371812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis.
    Bertin H; Moussa MS; Komarova S
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1103-1119. PubMed ID: 37632645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
    J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood.
    Chan B; Zacharin M
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):75-80. PubMed ID: 16509531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome.
    Lala R; Matarazzo P; Bertelloni S; Buzi F; Rigon F; de Sanctis C
    Acta Paediatr; 2000 Feb; 89(2):188-93. PubMed ID: 10709889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.
    Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrous dysplasia with intramuscular myxoma (Mazabraud's syndrome). Report of a case and review of the literature.
    Thomachot B; Daumen-Legre V; Pham T; Acquaviva PC; Lafforgue P
    Rev Rhum Engl Ed; 1999 Mar; 66(3):180-3. PubMed ID: 10327500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of developing spontaneous MRONJ in fibrous dysplasia patients treated with bisphosphonates: a systematic review of the literature.
    Nadella S; Mupparapu M; Akintoye SO
    Quintessence Int; 2022 Jun; 53(7):616-623. PubMed ID: 35674165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.
    Kochar IP; Kulkarni KP
    Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects].
    Egner-Höbarth S; Welkerling H; Windhager R
    Orthopade; 2007 Feb; 36(2):124, 126-30. PubMed ID: 17277960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate therapy in polyostotic fibrous dysplasia.
    Kumar S
    Indian Pediatr; 2004 Oct; 41(10):1069-70. PubMed ID: 15523142
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical management of fibrous dysplasia in McCune-Albright syndrome.
    Stanton RP; Diamond L
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():446-52. PubMed ID: 17982394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrous dysplasia].
    Rödl R; Götze C
    Orthopade; 2008 Jan; 37(1):49-55. PubMed ID: 18084739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.